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1. Introduction 
This document summarises responses received to the UK-wide public consultation (in 
accordance with section 129(6) of the Medicines Act 1968) which ran from 10 March 2017 
to 5 May 2017 on proposed changes to the Human Medicines Regulations 2012, to allow 
schools to hold spare adrenaline auto-injectors (AAI), without a named individual 
prescription, for use in emergencies. Over 500 people completed an online form hosted on 
https://consultations.dh.gov.uk/hmr/adrenaline-auto-injectors/ 
 
Respondents included parents, schools, education authorities, school nurses, consultant 
paediatric immunologists and allergy specialists, general practitioners, pharmacists and key 
organisations (which are listed in Annex B). 
 
Under the Human Medicines Regulations 2012, AAIs are prescription-only medicines and 
schools cannot hold their own AAIs for use in emergencies.  
Anaphylaxis is a severe, potentially life-threatening, allergic reaction for which the 
recommended treatment is an injection of adrenaline.  
AAIs are potentially life-saving products prescribed to people at risk of anaphylaxis which 
enable the administration of adrenaline by non-healthcare professionals. 
Children and young people at risk of anaphylaxis are prescribed AAIs and should have two 
available to them at all times but evidence suggests that children may not bring their 
prescribed AAIs to school or that the AAIs may be out of date or may misfire. 
The response template used for this consultation, which includes specific questions for 
respondents, is included at Annex A.  
 
In the following summary, the names of individuals have not been given; however, direct 
quotations have been made where respondents have indicated willingness for their 
comments to be made available.  
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2. Summary of responses  
The following summary is organised following the order of the topics as set out in the 
consultation response template (Annex A).  
 
A. Support for the proposals  
 
There was overwhelming support for the proposals. 533 respondents supported the 
proposals to allow schools to hold spare AAIs, without a prescription, for use in 
emergencies and 33 respondents said they had no comments to make on the proposals. 
However, three respondents highlighted that there was not an option to disagree with the 
proposals and would have welcomed the opportunity to respond with, "I do not support the 
proposal."  
 
Many respondents made important points in relation to safe practice by schools in their 
management and storage of AAIs, staff training and ensuring that a valid consent from 
parents/guardians has been given to schools in case there is a situation where they need to 
administer the spare AAI. A number of parents of children with allergies who responded to 
the consultation said they would be reassured knowing that the school held a spare AAI in 
case their child had an allergic reaction while at school. 
 
A small number of respondents questioned whether it should be mandatory for schools to 
hold a spare AAI. Another respondent stated that before amending the legislation it would 
be helpful to understand if schools would actually buy a spare AAI to keep at school. A 
small number of respondents stated that a school that chose to purchase a spare AAI 
should not have to pay for the AAI out of the school’s budget. 
 
A respondent who did not support the proposals to allow schools to hold spare AAIs, without 
a prescription, for use in emergencies said they felt the proposals placed an unnecessary 
extra burden on schools.  
 
In relation to the guidance on AAIs, several respondents said that advice should be included 
on the supply, storage, care and disposal of AAIs and training of staff. A number of 
respondents said the guidance should make clear that any spare AAI held by a school 
should not be seen as a replacement for a pupils’ own device. A number of respondents 
said that advice on whether there is any difference between the different brands of AAI 
should be included and several respondents requested that the guidance included a section 
on what a school should do if they have a child who has an anaphylactic reaction, but hasn't 
been prescribed an AAI. These issues will all be covered in the Department of Health’s 
guidance for schools which will be issued before the regulatory change comes into effect on 
1st October.  
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B. The relevance and impact of the criteria 
 
This section of the consultation asked questions on current practice, the likely intentions of 
respondents (particularly schools), and key issues relevant to implementation. The 
questions to which comments refer are underlined. Direct quotations are italicised.  
 
If you come into regular contact with a child/children at risk of anaphylaxis or work in a 
school or education environment please indicate in what capacity you have contact with 
children at risk of anaphylaxis.  
 
This was a multiple choice question. Respondents answered as follows: 
 
School   179 
Education Authority  18 
Parent   211 
Doctor of Health Worker 109 
Other     62 
 
 
Do you think this proposal would allow schools to access/receive AAIs? What could be the 
implementation issues?  
 
365 respondents answered this question. The consensus was that the proposals were 
suitable for allowing schools to hold spare AAIs, without a prescription, for use in 
emergencies, provided schools had a reasonable AAI policy, in line with guidance, and 
school staff were properly trained and supported. Implementation issues raised by 
respondents were around the cost of the spare AAI and who would be expected to pay for 
the device. 
 
“No issues that I can for see as long as staff are trained to fully recognise signs and parents 
are informed of the school policy.” 
            Individual 
 
 
“Cost would no doubt be a factor if schools are having to purchase their own on already 
tight budgets.” 
            Individual 
 
 
“There could be funding issues, although I think most PTAs would be open to fundraising 
specifically for this purpose once the legislation is approved.” 
            Individual  
 
 
If you are aware of a school that has pupils at risk of anaphylaxis can you confirm whether 
the school has existing protocols in place for the use of AAIs? Are staff trained in the 
administration of AAIs? 
 
364 respondents answered this question. The majority of respondents were aware of a 
school that has pupils at risk of anaphylaxis having existing protocols in place for use of 
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AAIs and trained staff to administer the AAIs. However, a small number of respondents said 
they were aware of a school that has pupils at risk of anaphylaxis but were either unsure 
whether the school had existing protocols in place for use of AAIs or said the school did not 
have existing protocols in place. Regarding staff training the majority of respondents said 
they were aware that school staff were trained in the administration of AAIs. However, this 
ranged from all staff been trained to a small number of staff been trained in the 
administration of AAIs. 
 
“We have pupils with severe nut allergies and we have protocols in place to deal with 
anaphylaxis. We have whole staff training once a year from our school nurse. The local 
authority has an indemnity policy that covers staff who administer AAI's. Fortunately we 
have never once had to use an AAI.” 
Afon Taf High School 
 
 
“No they do not. The school only have care plans for those children with epipens or risk of 
anaphylaxis.” 
Individual 
 
 
“Yes - the school has protocols in place and all staff are trained in the administration of 
AAIs.” 
St. Anthony’s School 
 
“The situation in schools is improving following the amendments to the Children and 
Families Bill in 2014 which places a duty of care on schools and many schools now have a 
plan in place for their students with health conditions. Additionally, most schools will have at 
least one member of staff trained in the use of emergency adrenaline. There are of course 
schools who have not adhered to the changes and indeed these changes only affected 
schools in England, so a robust set of guidelines and some basic training are essential as 
part of these changes.” 
The Anaphylaxis Campaign 
 
 
If the school you are referring to became eligible for access to AAIs, would it consider 
holding a spare device in its premises?  
 
This was a multiple choice question. Respondents answered as follows: 
 
Yes   260 
No    19 
Not Answered 274 
 
 
If you answered the above question with yes, can you please indicate how many AAIs you 
are expecting to request/buy and use in a twelve month period under this proposal?  
 
251 respondents answered this question. A range of responses were received to this 
question. The most common response was that  people expected to request/buy 1 to 3 
devices in a twelve month period under this proposal. Other responses ranged from 4 to 6 
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and from 8 to 12 devices. A small number of respondents said they were unable to answer 
this question and other respondents said this would be dependent on the cost of the devices 
and the decision of the school. 
 
“I would suggest 2 pens kept by the school at any one time. Replaced if used or expired.” 
Individual 
 
 
“Depends on cost incurred.” 
Individual 
 
 
“12 AAIs (2 for each classroom).” 
Individual 
 
 
If the school you are referring to held a spare AAI would additional training in its 
administration be necessary? 
 
This was a multiple choice question. Respondents answered as follows: 
 
Yes   155 
No    164 
Not Answered 232 
 
 
Can you identify any practical problems if schools are allowed to supply AAIs for emergency 
use? 
 
324 respondents answered this question. Several respondents said they could not identify 
any practical problems if schools are allowed to supply AAIs for emergency use. A large 
number of respondents identified a range of practical issues that would need to addressed 
including:  
 
 ensuring that a valid consent from parents/guardians has been obtained in case the 
spare AAI needs to be administered by the school;  
 the dosage which would need to be administered if a child went into anaphylactic 
shock;  
 instructions on how to administer the AAI and advice on what to do if the AAI mis-
fires;  
 what to do if staff misdiagnose a child as having an anaphylactic shock and 
administer the AAI; 
  the storage of AAIs;  
 monitoring of AAI expiry dates,;  
 how to dispose of out of date AAIs,  
 staff training;  
 the costs involved with purchasing a spare AAI,  
 protocols for when children with allergies go on school trips or when children with 
allergies are off site;  
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 guidance for staff on how to manage an allergic reaction in a child who has not been 
prescribed an AAI or in a child who is experiencing their first allergic reaction. 
 
“In secondary schools where the pupils can be off site, such as at sports fields, or on a large 
campus like setting the location of the AAI maybe a significant distance from the pupil. A 
high school pupil at risk of anaphylaxis should carry their own AAI, but if they forget, they 
would need to access the generic AAI if needed. School policy should cover offsite locations 
etc and take into consideration how it deals with these types of scenarios, to safeguard 'at 
risk' pupils.” 
Allergy UK 
 “The AAI must be in a known and accessible place but safe from unauthorised access.” 
Individual  
 
 
“The only problem I see is that all parents would have to give consent for use on their 
children and this information would require updating regularly? Also the cost involved?” 
Individual 
 
“Dose and product selection.  
By the time the auto injector is obtained, pupil may not be able to self-inject. 
Cost 
Mis "diagnosis" of anaphylaxis” 
Primary and Community Care Pharmacy Network 
 
 
Do you think this could encourage parents to not make sure that their children have AAIs 
when they go to school?  
 
This was a multiple choice question. Respondents answered as follows: 
 
Yes    131 
No    360 
No Answered  59 
 
 
Are you aware of any incidences of anaphylactic reaction where the pupil could not use their 
own AAIs, in the past 12 months?  
 
This was a multiple choice question. Respondents answered as follows: 
 
Yes    69 
No    371 
Not Answered  11 
 
 
If you are a manufacturer of AAIs: Considering the likely demand for AAIs among the 
eligible groups under this proposal, how many additional AAIs might you expect to sell per 
year?  
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Manufacturers were asked for their views on likely demand. Only one manufacturer replied 
to this question and a small number of individuals gave estimates. 
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3. Our response and next steps  
The Department of Health and the Medicines and Healthcare Products Regulatory Agency 
are grateful to everyone who has taken the time to respond to this consultation.  
 
The responses received were overwhelmingly supportive of changing the law to allow 
schools to hold spare AAIs, without a prescription, for use in emergencies. The Government 
therefore laid before Parliament on 5 July 2017 the Human Medicines (Amendment) 
Regulations 2017. http://www.legislation.gov.uk/id/uksi/2017/715. 
 
These Regulations amend the Human Medicines Regulations 2012, to allow schools to hold 
spare AAIs, without a prescription, for use in emergencies. These regulations come into 
effect on 1 October 2017. 
 
From this date onwards, schools can buy AAIs, without a prescription, for use in 
emergencies from a pharmaceutical supplier in small quantities provided it is done on an 
occasional basis and is not for profit. 
 
A supplier will need a request signed by the principal or head teacher (ideally on 
appropriately headed paper) stating:  
 
 the name of the school for which the product is required; 
 the purpose for which that product is required, and 
 the total quantity required.  
 
The Department of Health is also producing non-statutory guidance to support schools in 
England in their management of AAIs.  
 
As Devolved Administrations, Wales, Northern Ireland and Scotland will have respective 
responsibility for issuing their own guidance to their schools.   
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Annex A: Original consultation response 
template  
Overview 
This consultation seeks views on whether legislation should be changed to allow schools to 
choose to hold spare adrenaline auto-injectors (AAIs) for use in emergencies. 
Currently, AAIs are prescription only medicines, which means that schools cannot keep 
spares for use in emergencies. Following the recommendation of the Commission on 
Human Medicines, the government is proposing to change the Human Medicines 
Regulations 2012 to enable schools to purchase and hold spare AAIs for use in 
emergencies. 
This would enable schools in England, Scotland, Wales and Northern Ireland that choose to 
do so to hold spare AAI for use in emergencies. No school would be required to hold spare 
AAIs as a result of the change. 
Introduction 
Anaphylaxis is a severe, potentially life-threatening, allergic reaction for which the 
recommended treatment is an injection of adrenaline.  
Auto-Injectors (AAIs) are potentially life-saving products prescribed to people at risk of 
anaphylaxis which enable the administration of adrenaline by non-professionals. 
Children and young people at risk of anaphylaxis are prescribed AAIs and should have two 
available to them at all times but evidence suggests that children may not bring their 
prescribed AAIs to school or that the AAIs may be out of date or may misfire. 
Currently AAIs are prescription only medicines which means that schools cannot keep 
spares for use in emergencies. Following the recommendation of the Commission on 
Human Medicines the Government is proposing to change the Human Medicines 
Regulations 2012 to enable schools to purchase and hold spare AAIs for use in 
emergencies. This would enable schools in England, Scotland, Wales and Northern Ireland 
which chose to do so to hold spare AAI for use in emergencies. No school would be 
required to hold spare AAIs as a result of the change. 
As well as changing the law, we will produce guidance for schools. This will provide advice 
on a range of issues in particular the symptoms of anaphylaxis, administration of AAIs, 
record-keeping and storage.  
In particular the guidance will be clear that: 
1. The school's spare AAIs are not a replacement for pupils' own devices. Pupils should 
continue to bring their own AAIs to schools. 
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2. Use of the spare AAI should be restricted to pupils prescribed an AAI whose parents 
have given consent for its use. 
3. Schools should hold a list of all pupils who can access the spare AAI. 
4. Where pupils are prescribed more than one brand of AAI, schools are free to decide 
whether to purchase one brand of AAI or each brand used by pupils. 
5. Schools should keep a record of the spare AAIs held and their expiry date and 
ensure they are replaced appropriately. 
We are asking for your comments on both the proposed changes to legislation and the 
proposed principles of the accompanying guidance. 
Tell us about yourself 
Question 1. What is your name?  
 
Title (Mr, Mrs, Ms, Dr, Professor)  
First name  
Surname  
 
Question 2. What is your email address?  
If you enter your email address then you will automatically receive an acknowledgement 
email when you submit your response. 
 
Email  
 
Question 3. Are you responding as an individual or as part of an organisation?  
Please select only one item 
 Individual  
 Organisation  
 
If you selected organisation, what is the name of your organisation? 
What is the role of your organisation? 
Where are you/your organisation based? 
Please select only one item 
 England  
 Wales  
 Scotland  
 Northern Ireland 
 Other  
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If other, please tell us where you or your organisation are based. 
Question 4. If you are responding as an individual, please tell us your ethnic origin:  
 
White 
Please select only one item 
 English / Welsh / Scottish / Northern Irish / British  
 Irish  
 Gypsy or Irish traveller  
 Any other white background, please describe:  
If other, please describe your ethnic origin  
 
Mixed/multiple ethnic groups 
Please select only one item 
 White and Black Caribbean  
 White and Black African  
 White and Asian  
 Any other mixed/multiple ethnic background, please describe:  
 
If other, please give details of your ethnic background.  
 
Asian/Asian British 
Please select only one item 
 Indian  
 Pakistani  
 Bangladeshi  
 Chinese  
 Any other Asian background – please describe:  
If other, please enter details of your ethnic background  
 
Black / African / Caribbean / Black British 
Please select only one item 
 African  
 Caribbean  
 Any other Black/African/Caribbean background, please describe:  
 
If other, please give details of your ethnic origin.  
 
Other ethnic group  
Please select only one item 
 Arab  
 Any other ethnic group, please describe:  
 
If other, please provide details of your ethnic background  
 
Prefer not to say 
Please select only one item 
 Prefer not to say  
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Consultation Questions 
If you are a manufacturer of AAIs please answer question 5 and then go to question 15 (you 
do not need to answer questions 6 to 14). 
Question 5. Your response to the proposals  
 
This question requires a response - Please select one of the following:- 
 I support the proposals.  
 I have no comments to make on the proposals.  
 
Please let us know if you have any comments on the proposals  
 
Please let us know if you have any comments on the issues intended to be addressed in the 
draft guidance  
 
Question 6. If you come into regular contact with a child/children at risk of anaphylaxis or 
work in a school or education environment please indicate in what capacity you have 
contact with children at risk of anaphylaxis.  
Multiple choice checkboxes  
Please select all that apply 
 
 School  
 Education authority  
 Parent  
 Doctor or health worker  
 Other  
 
If you ticked other please specify below  
 
Question 7. Do you think this proposal would allow schools to access/receive AAIs? What 
could be the implementation issues?  
 
Comments  
 
Question 8. If you are aware of a school that has pupils at risk of anaphylaxis can you 
confirm whether the school has existing protocols in place for the use of AAIs? Are staff 
trained in the administration of AAIs?  
 
Comments  
 
Question 9. If the school you are referring to became eligible for access to AAIs, would it 
consider holding a spare device in its premises?  
 
Multiple choice checkboxes  
Please select all that apply 
 Yes  
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 No  
 
Question 10. If you answered the above question with yes, can you please indicate how 
many AAIs you are expecting to request/buy and use in a twelve month period under this 
proposal?  
 
Comments  
 
Question 11. If the school you are referring to held a spare AAI would additional training in 
its administration be necessary?  
Please select all that apply 
 Yes 
 No  
 
Question 12. Can you identify any practical problems if schools are allowed to supply AAIs 
for emergency use?  
 
Comments  
 
Question 13. Do you think this could encourage parents to not make sure that their children 
have AAIs when they go to school?  
Multiple choice checkboxes  
Please select all that apply 
 Yes 
 No  
 
Question 14. Are you aware of any incidences of anaphylactic reaction where the pupil 
could not use their own AAIs, in the past 12 months?  
 
Multiple choice checkboxes  
Please select all that apply 
 Yes  
 No  
 
Question 15. If you are a manufacturer of AAIs: Considering the likely demand for AAIs 
among the eligible groups under this proposal, how many additional AAIs might you expect 
to sell per year?  
 
Comments  
 
Question 16. Are you happy for the Department of Health to use your email address to 
contact you to clarify points in your response if necessary?  
Single choice radio buttons  
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Please select only one item 
 Yes  
 No  
 
Question 17. How we will use your response  
We might share your response with other government policy teams who may be addressing 
the issues you discuss. They may wish to contact you again in the future. We need your 
permission to do this. Are you content for a government policy official to use your email 
address to contact you in relation to this consultation response?  
 Please select only one item 
 Yes  
 No  
 
Are you content for the policy team to use your response and/or name in the final published 
report? 
Please select only one item 
 Yes  
 No  
If yes, please tick if we can use the following information about: 
Please select all that apply 
 Your response  
 Your name (individual name)  
 Your organisation’s name  
 
Question18. Would you like to receive information about other DH consultations?  
Please select only one item 
 Yes  
 No  
 
Question 19. Help us improve how the department runs consultations by answering the 
following questions:  
How satisfied are you with the consultation process? 
Please select only one item 
 Very satisfied  
 Satisfied  
 Somewhat satisfied  
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 Disappointed  
 
Further comments:  
How satisfied are you with the digital consultation experience? 
Please select only one item 
 Very satisfied  
 Satisfied  
 Somewhat satisfied  
 Disappointed  
 
Further comments:  
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Annex B: List of organisational respondents 
to the consultation 
The below list of organisations agreed to the Department of Health publishing their names in 
the response to the consultation: 
 
Aberdeenshire Council 
Afon Taf High School 
Allergy Action 
Allergy UK 
Ambulance Pharmacists Network 
Antrim Grammar School 
Ashtons Hospital Pharmacy Services Ltd 
Association of School and College Leaders (ASCL) 
Bedford Modern School  
Blue Door Nursery 
Central North West London NHS Foundation Trust 
Community Pharmacy Wales 
County Durham and Darlington NHS Trust 
Down High School 
Executive Training Ltd 
Fane Street Primary School 
Guild of Healthcare Pharmacists  
International School of Aberdeen 
Law Society of Northern Ireland 
Leeds Children's Hospital 
Market Bosworth School 
Moulsford Boys' Prep School 
National Pharmacy Association 
NHS Lothian 
North West Paediatric Allergy Network 
Paediatric Committee of British Society for Allergy & Clinical Immunology 
Powys County Council 
Primary and Community Care Pharmacy Network (PCCPN) 
Renfrewshire Council 
Rescue Emergency Care 
Royal Belfast Academical Institution 
Royal Manchester Children's Hospital 
Royal Pharmaceutical Society 
Scarborough College 
Scottish Outdoor Education Centres 
Seaview P.S 
Severe Allergy Group - West Yorkshire 
SNAP Cymru 
Southern Health and Social Care Trust 
Southern Trust Children and Young People 
ST4 Training 
St. Anthony's School 
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St. Francis' Primary School, Lurgan, NI 
St. George's University Hospitals NHS Foundation Trust 
St. Johns School 
St. Joseph's High School, Crossmaglen 
St. Mark's High School, Warrenpoint 
St. Mary's P.S. 
St. Peter's School 
The Anaphylaxis Campaign 
The London Football Academy 
The Royal College of Paediatrics and Child Health 
Tor Bank Special School 
Western Sussex Hospitals Trust 
West Essex Children Services 
Wilmslow High School 
 
 
  
 
